![]() |
인쇄하기
취소
|
As a rumor of registering anti-smoking treatments in the health insurance benefit this October at the earliest spreads, competition between ‘Champix(generic name: varenicline)’ and ‘Nicopion(generic name: bupropion)’ is expected to be fiercer. At the present, market share of Champix is estimated at approximately 70%. Market share of Nicopion seems to be 30% at most.
Considering recognition and...